Sex and survival outcomes in patients with renal cell carcinoma receiving first-line immune-based combinations.
Saved in:
| Title: | Sex and survival outcomes in patients with renal cell carcinoma receiving first-line immune-based combinations. |
|---|---|
| Authors: | Incorvaia L; Department of Precision Medicine in Medical, Surgical and Critical Care (Me.Pre.C.C.), Section of Medical Oncology, University of Palermo, 90127, Palermo, Italy. lorena.incorvaia@unipa.it., Monteiro FSM; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, RS, Brazil. fsabinocba@gmail.com.; Oncology and Hematology Department, Hospital Sírio-Libanês, Brasilia, DF, Brazil. fsabinocba@gmail.com., Massari F; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy.; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy., Park SH; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 06351, Republic of Korea., Roviello G; Department of Health Sciences, University of Florence, Florence, Italy., Fiala O; Department of Oncology and Radiotherapeutics, Faculty of Medicine and University Hospital in Pilsen, Charles University, Alej Svobody 80, Pilsen, 304 60, Czech Republic.; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 76, Pilsen, Czech Republic., Myint ZW; Markey Cancer Center, University of Kentucky, Lexington, KY, 40536-0293, USA., Kucharz J; Department of Uro-Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Molina-Cerrillo J; Department of Medical Oncology, University Hospital Ramón y Cajal, Madrid, Spain., Santini D; Department of Medical-Surgical Sciences and Biotechnology, La Sapienza University, Polo Pontino, Rome, Italy., Buttner T; Department of Urology, University Hospital Bonn (UKB), 53127, Bonn, Germany., Poprach A; Department of Comprehensive Cancer Care and Faculty of Medicine, Masaryk Memorial Cancer Institute and Masaryk University, Brno, Czech Republic., Kopecky J; Department of Clinical Oncology and Radiotherapy, University Hospital Hradec Kralove, Hradec Kralove, Czechia., Zeppellini A; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Pichler M; Division of Oncology, Department of Internal Medicine, Medical University of Graz, 8036, Graz, Austria., Buchler T; Department of Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic., Pichler R; Department of Urology, Medical University of Innsbruck, Innsbruck, Austria., Facchini G; Oncology Unit, 'S. Maria Delle Grazie' Hospital, ASL NA2 NORD, 80078, Pozzuoli, Naples, Italy., Fay AP; PUCRS School of Medicine, Porto Alegre, RS, Brazil., Soares A; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Oncology and Hematology Center of Hospital Albert Einstein, Hospital Albert Einstein, Sao Paulo, Brazil., Manneh R; Clinical Oncology, Sociedad de Oncología Y Hematología del Cesar, Valledupar, Colombia., Iezzi L; Oncology Division, Hospital 'Maria SS. Dello Splendore' ASL 4, Giulianova, Italy., Kuronya Z; Department of Genitourinary Medical Oncology and Clinical Pharmacology, National Institute of Oncology, Budapest, Hungary., Russo A; Department of Precision Medicine in Medical, Surgical and Critical Care (Me.Pre.C.C.), Section of Medical Oncology, University of Palermo, 90127, Palermo, Italy., Bourlon MT; Hematology and Oncology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico., Bhuva D; Department of Medical Oncology, Army Hospital Research and Referral, New Delhi, India., Ansari J; Medical Oncology, Tawam Hospital, Al Ain, United Arab Emirates., Kanesvaran R; National Cancer Centre Singapore, Singapore, Republic of Singapore., Grande E; Department of Medical Oncology, MD Anderson Cancer Center Madrid, Madrid, Spain., Buti S; Department of Medicine and Surgery, University of Parma, Via Gramsci 14, 43126, Parma, Italy.; Oncology Unit, University Hospital of Parma, Via Gramsci 14, 43126, Parma, Italy., Santoni M; Oncology Unit, Macerata Hospital, Macerata, Italy. |
| Source: | Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2024 Jun 04; Vol. 73 (8), pp. 142. Date of Electronic Publication: 2024 Jun 04. |
| Publication Type: | Journal Article; Multicenter Study; Observational Study |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1432-0851 |
|---|---|
| DOI: | 10.1007/s00262-024-03719-0 |
